Numerous industries have complained about the costs they currently have to pay for getting the approval process through. But more importantly to them, and to Canadians, was the length of time it takes to get drug approvals through. And that's not full cost recovery. So I gather, under this, there's going to be a significant increase in the costs that the industry is going to pay to get that process through. But has there been any intent here to beef up the process so that it doesn't drag on for such a long period of time, given the fact that they're going to be asked for additional dollars to ensure that the funding process goes through?
On February 12th, 2007. See this statement in context.